Management and clinical thinking of Coronavirus Disease 2019

VernacularTitle: 2019新型冠状病毒感染肺炎的临床思考及处理
Author: Ke MA ¹ ; Tao CHEN ; Meifang HAN ; Wei GUO ; Qin NING
Author Information

1. Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Publication Type:Journal Article
Keywords: 2019 novel coronavirus; Corona virus disease 2019; Diagnosis; Treatment
From: Chinese Journal of Hepatology 2020;28(0):E002-E002
CountryChina
Language:Chinese
Abstract: In December 2019, the 2019 novel coronavirus pneumonia (NCP, officially named Coronavirus Disease 2019(COVID-19) by the World Health Organization) broke out in Wuhan, Hubei, and it quickly spread to the whole country and abroad. The situation was at stake. The sudden and serious COVID-19 epidemic has brought us a lot of urgent problems. How to effectively control the spread of COVID-19? When does the population infection rate rise to its peak? What will eventually be the number of infected patients? How to make early diagnosis? What effective antiviral drugs are available? How to effectively treat with existing drugs? Can it successfully improve the survival rate of critically patients? In response to the above questions, we put forward corresponding suggestions and reflections from the perspective of the infectious clinician.